Acute lymphoblastic leukemia in older adults: curtain call for conventional chemotherapy?

被引：13

作者：

Luskin, Marlise R. ^{[1
]}

机构：

[1] Dana Farber Canc Inst, Dept Med Oncol, Div Leukemia, 450 Brookline Ave,Dana 2056, Boston, MA 02115 USA

来源：

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM | 2021年 / 01期

关键词：

LOW-INTENSITY CHEMOTHERAPY; PHILADELPHIA-CHROMOSOME; ELDERLY-PATIENTS; INOTUZUMAB OZOGAMICIN; HYPERFRACTIONATED CYCLOPHOSPHAMIDE; REMISSION INDUCTION; 1ST-LINE TREATMENT; PHASE-II; COMBINATION; DASATINIB;

D O I：

10.1182/hematology.2021000226

中图分类号：

G40 [教育学];

学科分类号：

040101 ; 120403 ;

摘要：

Unlike younger adults with acute lymphoblastic leukemia (ALL), older adults are rarely cured due to a combination of intrinsic disease resistance and treatment-related toxicities. Novel therapeutics such as inotuzumab ozogamicin, blinatumomab, venetoclax, and ABL kinase inhibitors have high activity in ALL and are well tolerated by older adults. Frontline treatment regimens for older adults using novel therapeutics with reduction or omission of conventional chemotherapy are being developed with early results demonstrating high remission rates and lower toxicity, but long-term efficacy and toxicity data are lacking. Collaboration between academic and pharmaceutical stakeholders is needed to develop clinical trials to define the optimal treatment regimens for older adults with ALL.

引用

页码：7 / 15

页数：9

共 48 条

[1] Results of SWOG 1318: A Phase 2 Trial of Blinatumomab Followed By Pomp (Prednisone, Vincristine, Methotrexate, 6-Mercaptopurine) Maintenance in Elderly Patients with Newly Diagnosed Philadelphia Chromosome Negative B-Cell Acute Lymphoblastic Leukemia [J].

Advani, Anjali S. ;

Moseley, Anna ;

O'Dwyer, Kristen Marie ;

Wood, Brent ;

Fang, Min ;

Wieduwilt, Matthew J. ;

Aldoss, Ibrahim ;

Park, Jae H. ;

Klisovic, Rebecca ;

Baer, Maria R. ;

Stock, Wendy ;

Bhave, Rupali ;

Othus, Megan ;

Litzow, Mark R. ;

Stone, Richard M. ;

Erba, Harry P. .

BLOOD, 2018, 132

[2] Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia [J].

Chalandon, Yves ;

Thomas, Xavier ;

Hayette, Sandrine ;

Cayuela, Jean-Michel ;

Abbal, Claire ;

Huguet, Francoise ;

Raffoux, Emmanuel ;

Leguay, Thibaut ;

Rousselot, Philippe ;

Lepretre, Stephane ;

Escoffre-Barbe, Martine ;

Maury, Sebastien ;

Berthon, Celine ;

Tavernier, Emmanuelle ;

Lambert, Jean-Francois ;

Lafage-Pochitaloff, Marina ;

Lheritier, Veronique ;

Chevret, Sylvie ;

Ifrah, Norbert ;

Dombret, Herve .

BLOOD, 2015, 125 (24) :3711-3719

[3] Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts [J].

Chiaretti, Sabina ;

Vitale, Antonella ;

Cazzaniga, Gianni ;

Orlando, Sonia Maria ;

Silvestri, Daniela ;

Fazi, Paola ;

Valsecchi, Maria Grazia ;

Elia, Loredana ;

Testi, Anna Maria ;

Mancini, Francesca ;

Conter, Valentino ;

Kronnie, Geertruy te ;

Ferrara, Felicetto ;

Di Raimondo, Francesco ;

Tedeschi, Alessandra ;

Fioritoni, Giuseppe ;

Fabbiano, Francesco ;

Meloni, Giovanna ;

Specchia, Giorgina ;

Pizzolo, Giovanni ;

Mandelli, Franco ;

Guarini, Anna ;

Basso, Giuseppe ;

Biondi, Andrea ;

Foa, Robin .

HAEMATOLOGICA, 2013, 98 (11) :1702-1710

[4] Maturation Stage of T-cell Acute Lymphoblastic Leukemia Determines BCL-2 versus BCL-XL Dependence and Sensitivity to ABT-199 [J].

Chonghaile, Triona Ni ;

Roderick, Justine E. ;

Glenfield, Cian ;

Ryan, Jeremy ;

Sallan, Stephen E. ;

Silverman, Lewis B. ;

Loh, Mignon L. ;

Hunger, Stephen P. ;

Wood, Brent ;

DeAngelo, Daniel J. ;

Stone, Richard ;

Harris, Marian ;

Gutierrez, Alejandro ;

Kelliher, Michelle A. ;

Letai, Anthony .

CANCER DISCOVERY, 2014, 4 (09) :1074-1087

[5] Long-term outcome of a pediatric-inspired regimen used for adults aged 18-50 years with newly diagnosed acute lymphoblastic leukemia [J].

DeAngelo, D. J. ;

Stevenson, K. E. ;

Dahlberg, S. E. ;

Silverman, L. B. ;

Couban, S. ;

Supko, J. G. ;

Amrein, P. C. ;

Ballen, K. K. ;

Seftel, M. D. ;

Turner, A. R. ;

Leber, B. ;

Howson-Jan, K. ;

Kelly, K. ;

Cohen, S. ;

Matthews, J. H. ;

Savoie, L. ;

Wadleigh, M. ;

Sirulnik, L. A. ;

Galinsky, I. ;

Neuberg, D. S. ;

Sallan, S. E. ;

Stone, R. M. .

LEUKEMIA, 2015, 29 (03) :526-534

[6] Inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: outcomes by disease burden [J].

DeAngelo, Daniel J. ;

Advani, Anjali S. ;

Marks, David, I ;

Stelljes, Matthias ;

Liedtke, Michaela ;

Stock, Wendy ;

Goekbuget, Nicola ;

Jabbour, Elias ;

Merchant, Akil ;

Wang, Tao ;

Vandendries, Erik ;

Neuhof, Alexander ;

Kantarjian, Hagop ;

O'Brien, Susan .

BLOOD CANCER JOURNAL, 2020, 10 (08)

[7] Efficacy and toxicity of reduced vs. standard dose pegylated asparaginase in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia [J].

Derman, Benjamin A. ;

Streck, Mitchell ;

Wynne, Joseph ;

Christ, Trevor N. ;

Curran, Emily ;

Stock, Wendy ;

Knoebel, Randall W. .

LEUKEMIA & LYMPHOMA, 2020, 61 (03) :614-622

[8] TEMPORARY REMISSIONS IN ACUTE LEUKEMIA IN CHILDREN PRODUCED BY FOLIC ACID ANTAGONIST, 4-AMINOPTEROYL-GLUTAMIC ACID (AMINOPTERIN) [J].

FARBER, S ;

DIAMOND, LK ;

MERCER, RD ;

SYLVESTER, RF ;

WOLFF, JA .

NEW ENGLAND JOURNAL OF MEDICINE, 1948, 238 (23) :787-793

[9] Phase 2 study of intensified chemotherapy and allogeneic hematopoietic stem cell transplantation for older patients with acute lymphoblastic leukemia [J].

Fathi, Amir T. ;

DeAngelo, Daniel J. ;

Stevenson, Kristen E. ;

Kolitz, Jonathan E. ;

Asch, Julie D. ;

Amrein, Philip C. ;

Attar, Eyal C. ;

Steensma, David P. ;

Wadleigh, Martha ;

Foster, Julia ;

Connolly, Christine ;

Galinsky, Ilene ;

Devoe, Craig E. ;

Stone, Richard M. ;

Neuberg, Donna S. ;

Ballen, Karen K. .

CANCER, 2016, 122 (15) :2379-2388

[10]

Fielding AK, 2019, HEMATOL-AM SOC HEMAT, P24, DOI 10.1182/hematology.2019000010

← 1 2 3 4 5 →